Five Prime Therapeutics, Inc.

Historical 13F Holders

Symbol
FPRX
CUSIP
33830X104
All holders as of
Q1 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q1 167 41.6 M $1.56 B
2020 Q4 148 41.4 M $700 M
2020 Q3 98 26.6 M $125 M
2020 Q2 101 27.3 M $167 M
2020 Q1 95 25.4 M $58.0 M
2019 Q4 97 27.3 M $125 M
2019 Q3 106 27.4 M $106 M
2019 Q2 124 28.6 M $173 M
2019 Q1 123 31.7 M $424 M
2018 Q4 124 31.3 M $291 M
2018 Q3 127 31.7 M $442 M
2018 Q2 133 31.3 M $494 M
2018 Q1 137 32.7 M $561 M
2017 Q4 148 26.1 M $573 M
2017 Q3 135 24.5 M $1.00 B
2017 Q2 129 24.5 M $737 M
2017 Q1 167 24.9 M $900 M
2016 Q4 177 25.2 M $1.26 B
2016 Q3 180 26.2 M $1.38 B
2016 Q2 179 24.6 M $1.02 B
2016 Q1 148 23.2 M $942 M
2015 Q4 137 22.2 M $921 M
2015 Q3 116 23.3 M $359 M
2015 Q2 108 20.3 M $504 M
2015 Q1 93 18.6 M $425 M
2014 Q4 71 13.7 M $369 M
2014 Q3 63 12.2 M $144 M
2014 Q2 63 11.5 M $178 M
2014 Q1 57 10.9 M $215 M